Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
暂无分享,去创建一个
Parag Aggarwal | Marina A Dobrovolskaia | Scott E McNeil | J. B. Hall | M. Dobrovolskaia | S. McNeil | Jennifer B Hall | Parag Aggarwal | C. McLeland | Christopher B McLeland
[1] S. Davis,et al. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.
[2] Kristen M Kulinowski,et al. Nanoparticles as catalysts for protein fibrillation , 2007, Proceedings of the National Academy of Sciences.
[3] Jean-Christophe Olivier,et al. Drug transport to brain with targeted nanoparticles , 2011, NeuroRX.
[4] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[5] J. Forrest,et al. Anomalous thermal denaturing of proteins adsorbed to nanoparticles , 2006, The European physical journal. E, Soft matter.
[6] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001 .
[7] Sudipta Seal,et al. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. , 2007, Biomaterials.
[8] P Couvreur,et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.
[9] M. Lück,et al. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[10] R. Müller,et al. In vitro characterization of poly(methyl-methaerylate) nanoparticles and correlation to their in vivo fate , 1992 .
[11] E. Gabellieri,et al. Dendrimer-protein interactions studied by tryptophan room temperature phosphorescence. , 2006, Biochimica et biophysica acta.
[12] Mitsuru Hashida,et al. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. , 2007, International journal of pharmaceutics.
[13] R. Müller,et al. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.
[14] J. McGrath,et al. Binding between particles and proteins in extracts: implications for microrheology and toxicity. , 2005, Acta biomaterialia.
[15] Patrick Soon-Shiong,et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] D. Hochstrasser,et al. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.
[17] Steven S. Vogel,et al. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[18] W. Maechtle. Analytical Ultracentrifugation of Polymers and Nanoparticles , 2006 .
[19] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[20] David Brown,et al. The pulmonary toxicology of ultrafine particles. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[21] M. Foote. Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel. , 2007, Biotechnology annual review.
[22] R. Müller,et al. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.
[23] S. Davis,et al. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. , 1994, Critical reviews in therapeutic drug carrier systems.
[24] Bengt-Harald Jonsson,et al. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[25] R. Mahley,et al. Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.
[26] Malcolm L. H. Green,et al. Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.
[27] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[28] W. MacNee,et al. Ultrafine (nanometre) particle mediated lung injury , 1998 .
[29] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[30] R. Gurny,et al. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.
[31] R. Müller,et al. Interactions of nanoparticles with body proteins--improvement of 2D-PAGE-analysis by internal standard. , 2000, International journal of pharmaceutics.
[32] K. Donaldson,et al. Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. , 2000, Inhalation toxicology.
[33] R. Müller,et al. Influence of Fluorescent Labelling of Polystyrene Particles on Phagocytic Uptake, Surface Hydrophobicity, and Plasma Protein Adsorption , 2004, Pharmaceutical Research.
[34] David D. Christ,et al. Chapter 33. Plasma Protein Binding of Drugs , 1996 .
[35] R. Kane,et al. Directed assembly of carbon nanotubes at liquid-liquid interfaces: nanoscale conveyors for interfacial biocatalysis. , 2006, Journal of the American Chemical Society.
[36] H. Kurz,et al. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. , 1977, Arzneimittel-Forschung.
[37] S M Moghimi,et al. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.
[38] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[39] J. Klein. Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[40] J. Kreuter,et al. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[41] Mansoor M. Amiji,et al. Nanotechnology for Cancer Therapy , 2006 .
[42] D. Meijer,et al. Molecular Mechanisms of the Adsorption of a Model Protein (Human Serum Albumin) on Poly(Methylidene Malonate 2.1.2) Nanoparticles , 2004, Pharmaceutical Research.
[43] Patrick Couvreur,et al. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. , 2007, Biomacromolecules.
[44] H M Patel,et al. Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.
[45] R. Müller,et al. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. , 2003, Journal of drug targeting.
[46] M. Frank,et al. The role of complement in inflammation and phagocytosis. , 1991, Immunology today.
[47] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] F. Zsila,et al. Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein. , 2008, Bioorganic & medicinal chemistry.
[49] V. Kolb-Bachofen,et al. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.
[50] E. Blomberg,et al. Probing protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[51] E. Schacht,et al. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. , 1998, Journal of pharmaceutical sciences.
[52] L. Illum,et al. Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.
[53] Patrick Soon-Shiong,et al. Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.
[54] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[55] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[56] A. Malik,et al. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function , 2002, Histochemistry and Cell Biology.
[57] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[58] Antonio Turiel,et al. Nanoparticle-mediated local and remote manipulation of protein aggregation. , 2006, Nano letters.
[59] H. Kiwada,et al. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. , 1987, Chemical and pharmaceutical bulletin.
[60] Y. Michotte,et al. The use of microdialysis for the determination of plasma protein binding of drugs. , 1992, Journal of pharmaceutical and biomedical analysis.
[61] Michael J Banker,et al. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. , 2003, Journal of pharmaceutical sciences.
[62] D. Tyrrell,et al. The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver. , 1977, Biochimica et biophysica acta.
[63] M. Dobrovolskaia,et al. Preclinical Characterization of Engineered Nanoparticles Intended for Cancer Therapeutics , 2006 .
[64] Moghimi,et al. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. , 1998, Advanced drug delivery reviews.
[65] A. Malik,et al. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[66] S. Radford,et al. Nucleation of protein fibrillation by nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[67] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[68] K. Higaki,et al. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. , 2007, International journal of pharmaceutics.
[69] Lawrence Tamarkin,et al. Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery , 2004, Drug delivery.
[70] A. Zahr,et al. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). , 2006, Langmuir : the ACS journal of surfaces and colloids.
[71] L. Låstbom,et al. Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. , 2002, Journal of applied physiology.
[72] M. Eriksson,et al. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis. , 2005, Journal of Pharmaceutical and Biomedical Analysis.
[73] Robert Gelein,et al. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. , 1992 .
[74] D. A. Kharkevich,et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.
[75] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[76] P. Predki,et al. Identification of small molecule targets on functional protein microarrays. , 2007, Methods in molecular biology.
[77] L. Balant,et al. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. , 1997, Journal of biomedical materials research.
[78] R. Müller,et al. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[79] S. K. Sundaram,et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[80] Dzmitry G. Shcharbin,et al. Effect of dendrimers on pure acetylcholinesterase activity and structure. , 2006, Bioelectrochemistry.
[81] L. Vroman,et al. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. , 1980, Blood.
[82] L. Illum,et al. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. , 1992, Biomaterials.
[83] W. Semmler,et al. Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation , 1997, Pharmaceutical Research.
[84] Scott E McNeil,et al. Nanotechnology for the biologist , 2005, Journal of leukocyte biology.
[85] M. Michaelis,et al. Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.
[86] J. Pawliszyn,et al. Determination of drug plasma protein binding by solid phase microextraction. , 2006, Journal of pharmaceutical sciences.
[87] T. Laue. Analytical Centrifugation: Equilibrium Approach , 1999, Current protocols in protein science.
[88] K. Higaki,et al. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[89] Ravi S Kane,et al. The protein-nanomaterial interface. , 2006, Current opinion in biotechnology.
[90] J. Kreuter,et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) , 1995, Brain Research.
[91] David Farrar,et al. Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. , 2006, Journal of the American Chemical Society.
[92] F. Ding,et al. Impacts of the surface charge property on protein adsorption on hydroxyapatite , 2002 .
[93] Ravi S Kane,et al. Structure and function of enzymes adsorbed onto single-walled carbon nanotubes. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[94] David M. Brown,et al. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.
[95] Yu-Chi Wang,et al. The sorption of lysozyme and ribonuclease onto ferromagnetic nickel powder 2. Desorption and competitive adsorption , 1995 .
[96] M. Poznansky,et al. Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.
[97] D. Tomalia,et al. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. , 2007, Biochemical Society transactions.
[98] S. Maiti,et al. Spontaneous formation of a protein corona prevents the loss of quantum dot fluorescence in physiological buffers , 2007 .
[99] Sara Linse,et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.
[100] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[101] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[102] Hong-Zhuan Chen,et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[103] P. Couvreur,et al. Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .
[104] J. Krieglstein,et al. Zur Plasmaproteinbindung von Arzneimitteln , 1969, Klinische Wochenschrift.
[105] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[106] Dzmitry G. Shcharbin,et al. Dendrimer Interactions with Hydrophobic Fluorescent Probes and Human Serum Albumin , 2005, Journal of Fluorescence.
[107] D. Fischer,et al. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[108] R. Müller,et al. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.
[109] Joseph D. Andrade,et al. Protein—surface interactions in the presence of polyethylene oxide , 1991 .
[110] O. Olsson,et al. 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. , 2006, Journal of proteome research.
[111] K. Avgoustakis,et al. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. , 2001, International journal of pharmaceutics.
[112] Sara Linse,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[113] R. Müller,et al. Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[114] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[115] S. Sant,et al. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. , 2008, Journal of biomedical materials research. Part A.
[116] J. Diederichs,et al. Plasma protein adsorption patterns on liposomes: Establishment of analytical procedure , 1996, Electrophoresis.
[117] Ravi S Kane,et al. Increasing protein stability through control of the nanoscale environment. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[118] I. Kariv,et al. Development of a high throughput equilibrium dialysis method. , 2001, Journal of pharmaceutical sciences.
[119] D. A. Kharkevich,et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles , 1995 .
[120] R. Müller,et al. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. , 1992, Clinical nutrition.
[121] John E. Coligan,et al. Current Protocols in Protein Science , 1996 .
[122] Rainer H Müller,et al. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. , 2003, Journal of biomedical materials research. Part A.
[123] K. Geiger,et al. Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles , 2004, International journal of cancer.
[124] M. Lück,et al. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.
[125] Robert Gurny,et al. Bioadhesion: Possibilities and Future Trends , 1990 .
[126] M. Bryszewska,et al. The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity. , 2004, Bioelectrochemistry.
[127] Jonathan S Dordick,et al. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[128] R. Müller,et al. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.
[129] S. Moghimi,et al. Capture of stealth nanoparticles by the body's defences. , 2001, Critical reviews in therapeutic drug carrier systems.
[130] P. Couvreur,et al. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system , 2007, Electrophoresis.
[131] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[132] R. Kato,et al. Studies on the mechanism of nitro reduction by rat liver. , 1969, Molecular pharmacology.
[133] J. Kreuter,et al. Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.